Suzhou Zelgen Biopharmaceuticals Co Ltd - Class A

NEW
SHSE:688266 (China)   Class A
Â¥ 138.34 +15.8 (+12.89%) Aug 20
66.51
P/B:
21.28
Market Cap:
Â¥ 36.62B ($ 5.44B)
Enterprise V:
Â¥ 30.78B ($ 4.57B)
Volume:
1.43B
Avg Vol (2M):
8.69M
Trade In:
Volume:
1.43B

Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) Dividend

Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -3.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: SHSE:688266 Dividend

Does Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) pay a dividend?

Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Suzhou Zelgen Biopharmaceuticals Co Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Suzhou Zelgen Biopharmaceuticals Co Ltd has returned capital to shareholders via buybacks at a rate of -3.3% over the past 3 years.

What are dividend-paying alternatives to Suzhou Zelgen Biopharmaceuticals Co Ltd?

For dividend-paying alternatives in Suzhou Zelgen Biopharmaceuticals Co Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.